重點導讀
Isomorphic Labs 宣佈完成 $5 Billion C 輪融資,投資方包括 Greenoaks、Sequoia Capital 和 Andreessen Horowitz,Alphabet 也持續投資。
- 這家公司由 Demis Hassabis 創立,目標是用 AI 設計和開發新藥。
- 貼文認為,AI 有望推動藥物研發,但沒有提供具體藥物、研究結果或進展時程。
AI 伴隨問答
針對這篇報導有疑問?可直接點選快捷問題或向 AI 追問背景脈絡與技術細節:
推薦理由
Isomorphic Labs 的新一輪融資顯示投資人正把資金投入 AI 藥物研發,可從中瞭解這個領域的資本動向。
🚨 AI News | TestingCatalog@testingcatalog
·5 天前
Isomorphic Labs raised $5 Billion in Series C funding from Greenoaks, Sequoia Capital and Andreessen Horowitz, with continued investment from Alphabet.
> Isomorphic Labs, founded by Demis Hassabis, is focussed on designing and developing new medicines with AI, ushering in a new era of biomedical breakthroughs.
Drug development is a huge area that everyone is expecting to get pushed forward by AI.
Soon? 👀
推文來源 · X (Twitter)在 X 參與討論
來源: 🚨 AI News | TestingCatalog (x.com)
在 X 查看推文